Afina W Lemstra Selected Research

Afina W Lemstra Research Topics

Disease

38	Dementia (Dementias) 03/2024 - 01/2003
25	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2003
20	Cognitive Dysfunction 04/2024 - 09/2008
8	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2003
5	Atrophy 02/2024 - 01/2018
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 01/2003
3	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 07/2013
3	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 01/2003
2	Orthostatic Hypotension (Postural Hypotension) 11/2023 - 01/2019
2	Disease Progression 01/2022 - 01/2019
2	Genetic Risk Score 01/2021 - 01/2021
2	Synucleinopathies 01/2018 - 01/2010
2	Hallucinations (Hallucination) 01/2008 - 01/2003
1	Proteostasis Deficiencies 05/2024
1	Neuroinflammatory Diseases 04/2024
1	Parkinsonian Disorders (Parkinsonism) 11/2023
1	Multiple System Atrophy 11/2023
1	Cerebral Small Vessel Diseases 11/2023
1	Tauopathies 01/2023
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2023
1	Vascular Remodeling 11/2022
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022
1	Sepsis (Septicemia) 01/2007
1	Psychomotor Agitation (Akathisia) 01/2003

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2010
16	Amyloid (Amyloid Fibrils)IBA 02/2024 - 10/2016
6	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2019
5	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2019
4	SynucleinsIBA 01/2021 - 01/2010
3	Amyloid beta-PeptidesIBA 05/2024 - 01/2022
3	ProteomeIBA 03/2024 - 11/2022
3	Dopamine (Intropin)FDA LinkGeneric 11/2023 - 01/2018
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2007 - 01/2003
2	Pemetrexed (MTA)FDA Link 02/2024 - 11/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
2	hydroxide ionIBA 11/2023 - 01/2019
2	PrionsIBA 01/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2014
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2018
2	Peptides (Polypeptides)IBA 10/2019 - 09/2019
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2019 - 01/2018
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 01/2003
1	alpha-SynucleinIBA 05/2024
1	HLA-DR Antigens (HLA-DR)IBA 05/2024
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 11/2023
1	thimet oligopeptidase (endo-oligopeptidase)IBA 07/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Codon (Codons)IBA 01/2022
1	sharpinIBA 01/2021
1	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	ioflupaneIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	EnzymesIBA 11/2018
1	ImmunosorbentsIBA 11/2018
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2018
1	Threonine (L-Threonine)FDA Link 01/2018
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 07/2013
1	AD 5IBA 07/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2008
1	LipopolysaccharidesIBA 01/2007

Therapy/Procedure

3	Therapeutics 11/2022 - 01/2003
1	Patient Care 04/2023
1	Neurosurgical Procedures 01/2023
1	Ligation 11/2022